The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nardelli, B.
Right arrow Articles by Alderson, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nardelli, B.
Right arrow Articles by Alderson, R. F.
The Journal of Immunology, 1999, 162: 435-444.
Copyright © 1999 by The American Association of Immunologists

Characterization of the Signal Transduction Pathway Activated in Human Monocytes and Dendritic Cells by MPIF-1, a Specific Ligand for CC Chemokine Receptor 1

Bernardetta Nardelli1,*, H. Lee Tiffany§, Gary W. Bong*, Pamela A. Yourey{dagger}, Diana K. Morahan*, Yuling Li{ddagger}, Philip M. Murphy§ and Ralph F. Alderson{dagger}

Departments of * Cell Biology, {dagger} Pharmacology, and {ddagger} Protein Expression, Human Genome Sciences, Inc., Rockville, MD 20850; and § Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892

The receptor specificity and signal transduction pathway has been identified and characterized for a truncated form of myeloid progenitor inhibitory factor-1 (MPIF-124–99). MPIF-1 binds specifically to sites, in particular CCR1, shared with macrophage inflammatory protein-1{alpha} (MIP-1{alpha}) on the surface of human monocytes and dendritic cells, as inferred by its ability to compete for [125I]MIP-1{alpha}, but not for [125I]MIP-1ß or [125I]monocyte chemotactic protein-1(MCP-1) binding to intact cells. Based on calcium flux, MPIF-1 is an agonist on CCR1-transfected HEK-293 cells, monocytes, and dendritic cells, but not on CCR5-, CCR8-, or CX3CR1-transfected cells. The inhibitory effect of guanosine 5'-O-(3-thio-triphosphate) (GTP-{gamma}S) or pertussis toxin pretreatment on MPIF-1 binding and calcium mobilization, respectively, indicates the involvement of G proteins in the interaction of MPIF-1 and its receptor(s). The increase in intracellular free calcium concentration following MPIF-1 treatment is mainly due to the influx of calcium from an extracellular pool. However, a portion of the intracellular free calcium concentration is derived from a phospholipase C inhibitor-sensitive intracellular pool. MPIF-1 induces a rapid dose-dependent release of [3H]arachidonic acid from monocytes that is dependent on extracellular calcium and is blocked by phospholipase A2 (PLA2) inhibitors. Furthermore, PLA2 activation is shown to be necessary for filamentous actin formation in monocytes. Thus, the MPIF-1 signal transduction pathway appears to include binding to CCR1; transduction by G proteins; effector function by phospholipase C, protein kinase C, calcium flux, and PLA2; and cytoskeletal remodeling.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
N. El Zein, B. Badran, and E. Sariban
VIP differentially activates {beta}2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1
J. Leukoc. Biol., April 1, 2008; 83(4): 972 - 981.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Novak, A. Muller, N. Harrer, C. Gunther, J. M. Carballido, and M. Woisetschlager
CCL23 Expression Is Induced by IL-4 in a STAT6-Dependent Fashion
J. Immunol., April 1, 2007; 178(7): 4335 - 4341.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. J. Cooper, B. Key, A. Carter, N. Z. Angel, D. N. J. Hart, and M. Kato
Suppression and Overexpression of Adenosylhomocysteine Hydrolase-like Protein 1 (AHCYL1) Influences Zebrafish Embryo Development: A POSSIBLE ROLE FOR AHCYL1 IN INOSITOL PHOSPHOLIPID SIGNALING
J. Biol. Chem., August 11, 2006; 281(32): 22471 - 22484.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. D. Berahovich, Z. Miao, Y. Wang, B. Premack, M. C. Howard, and T. J. Schall
Proteolytic Activation of Alternative CCR1 Ligands in Inflammation
J. Immunol., June 1, 2005; 174(11): 7341 - 7351.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Partida-Sanchez, P. Iribarren, M. E. Moreno-Garcia, J.-L. Gao, P. M. Murphy, N. Oppenheimer, J. M. Wang, and F. E. Lund
Chemotaxis and Calcium Responses of Phagocytes to Formyl Peptide Receptor Ligands Is Differentially Regulated by Cyclic ADP Ribose
J. Immunol., February 1, 2004; 172(3): 1896 - 1906.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Fantuzzi, F. Spadaro, G. Vallanti, I. Canini, C. Ramoni, E. Vicenzi, F. Belardelli, G. Poli, and S. Gessani
Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages
Blood, October 1, 2003; 102(7): 2334 - 2337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Sato, H. Kawasaki, C. Morimoto, N. Yamashima, and T. Matsuyama
An Abortive Ligand-Induced Activation of CCR1-Mediated Downstream Signaling Event and a Deficiency of CCR5 Expression Are Associated with the Hyporesponsiveness of Human Naive CD4+ T Cells to CCL3 and CCL5
J. Immunol., June 15, 2002; 168(12): 6263 - 6272.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Kito, K. Morishita, and K. Nishida
MCP-1 receptor binding affinity is up-regulated by pre-stimulation with MCP-1 in an actin polymerization-dependent manner
J. Leukoc. Biol., April 1, 2001; 69(4): 666 - 674.
[Abstract] [Full Text]


Home page
BloodHome page
O. M. Z. Howard, H. F. Dong, A.-K. Shirakawa, and J. J. Oppenheim
LEC induces chemotaxis and adhesion by interacting with CCR1 and CCR8
Blood, August 1, 2000; 96(3): 840 - 845.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. M. Murphy, M. Baggiolini, I. F. Charo, C. A. Hebert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Pharmacol. Rev., March 1, 2000; 52(1): 145 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Rajarathnam, Y. Li, T. Rohrer, and R. Gentz
Solution Structure and Dynamics of Myeloid Progenitor Inhibitory Factor-1 (MPIF-1), A Novel Monomeric CC Chemokine
J. Biol. Chem., February 9, 2001; 276(7): 4909 - 4916.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.